Cognition Therapeutics (CGTX) Share-based Compensation (2020 - 2026)
Cognition Therapeutics (CGTX) posted quarterly Share-based Compensation of $3.9 million for Q1 2026, up 559.22% year-over-year from $586000.0 in Q1 2025, and up 979.05% quarter-over-quarter from $358000.0 in Q4 2025.
Cognition Therapeutics (CGTX) Share-based Compensation (2020 - 2026) Analysis & Trends
Cognition Therapeutics (CGTX) has reported Share-based Compensation for 7 consecutive years, with $3.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Share-based Compensation rose 559.22% year-over-year to $3.9 million; the TTM figure through Mar 2026 stood at $3.9 million (up 945.3% YoY), while the FY2025 annual figure was $2.1 million, up 1.56% from the prior year.
- Share-based Compensation improved to $3.9 million in Q1 2026 per CGTX's latest filing, from $358000.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $3.9 million in Q1 2026 and bottomed at -$3.1 million in Q4 2024.
- Historically, Share-based Compensation has averaged $953529.4 across 5 years, with a median of $1.0 million in 2022.
- Annual changes were most pronounced in 2022 — Share-based Compensation surged 979.17% — and 2024, when it plunged 388.14%.
- Cognition Therapeutics' Share-based Compensation stood at $902000.0 in 2022, then grew by 18.74% to $1.1 million in 2023, then plunged by 388.14% to -$3.1 million in 2024, then soared by 111.6% to $358000.0 in 2025, then soared by 979.05% to $3.9 million in 2026.
- Business Quant data shows CGTX's Share-based Compensation at $3.9 million in Q1 2026, $358000.0 in Q4 2025, and $522000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.29 Bn | 131.44 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 86.31 Bn | 78.32 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 65.22 Bn | 60.03 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.92 Bn | 53.78 Bn | 52.00 Mn | 120.00 Mn |
| 5 | BeOne Medicines | 42.07 Bn | 36.97 Bn | 1.53 Bn | 137.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.70 Bn | 28.39 Bn | 992.69 Mn | 86.63 Mn |
| 7 | BioNTech SE | 27.99 Bn | 9.60 Bn | 668.28 Mn | 28.05 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 41.25 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - | - |
| 10 | Cognition Therapeutics | 89.63 Mn | 89.63 Mn | - | 3.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.43 Mn |
| Jun 30, 2026 | 3.43 Mn |
| Mar 31, 2026 | 3.86 Mn |
| Mar 31, 2026 | 3.86 Mn |
| Dec 31, 2025 | 358,000.00 |
| Dec 31, 2025 | 358,000.00 |
| Sep 30, 2025 | 522,000.00 |
| Sep 30, 2025 | 522,000.00 |
| Jun 30, 2025 | 2.83 Mn |
| Jun 30, 2025 | 2.83 Mn |
| Mar 31, 2025 | 586,000.00 |
| Mar 31, 2025 | 586,000.00 |
| Dec 31, 2024 | -3.09 Mn |
| Dec 31, 2024 | -3.09 Mn |
| Sep 30, 2024 | 896,000.00 |
| Sep 30, 2024 | 896,000.00 |
| Jun 30, 2024 | 1.15 Mn |
| Jun 30, 2024 | 1.15 Mn |
| Mar 31, 2024 | 1.17 Mn |
| Mar 31, 2024 | 1.17 Mn |